Metformin, a well-known medication for managing type 2 diabetes, may offer surprising benefits beyond controlling blood sugar levels. Recent research suggests that it can lower the risk of sudden sensorineural hearing loss (SSNHL) in a way that depends on the dosage. SSNHL is a rapid and often unexplained hearing loss that can significantly affect quality of life.
The study revealed that patients taking metformin had better survival rates overall compared to those who did not. This highlights the potential of metformin to improve health in ways that extend beyond its primary use in diabetes care.
These findings suggest that metformin could play a broader role in protecting the health of people with diabetes. By addressing both hearing health and long-term survival, it opens up new possibilities for improving patient outcomes.
While more research is needed to confirm and fully understand these benefits, this discovery adds to the growing list of reasons why metformin remains a cornerstone in managing type 2 diabetes.
